We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Wednesday, TScan Therapeutics, Inc. (NASDAQ: TCRX) received positive remarks from TD Cowen following an update on its clinical ...

Dimensional Fund Advisors LP increased its stake in TScan Therapeutics by 108.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 280,028 shares of the company’s stock valued at $ ...

3/6/2025 – TScan Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock. 3/5/2025 – TScan Therapeutics had its ...

TScan Therapeutics Inc. (NASDAQ:TCRX), a biotechnology company specializing in T-cell receptor (TCR) therapies with a market capitalization of $102 million, is navigating a critical phase in its ...

Channel 5 has rebranded to ‘5’ across its linear, streaming and digital platforms in a move aimed at strengthening perceptions of its content quality and range. The change, effective today (12 March), ...

“This isn't just a retro pastiche. The 5 is almost as joyful to use as it is to look at. Strong value cements the appeal” The cold rational left-brain summary is simple. The Renault 5 is an ...